Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events.

OBJECTIVES We sought to assess prospectively whether patients with normal coronary angiograms but with impaired myocardial blood flow (MBF) increases to cold pressor testing (CPT) are at increased risk for cardiovascular events. BACKGROUND Invasive angiographic assessments of coronary vasomotor function have demonstrated an impairment of endothelium-related coronary flow increases to independently predict future cardiovascular events. It is unknown whether noninvasive positron emission tomography (PET)-measured MBF alterations to sympathetic stimulation with CPT are associated with the risk of developing cardiovascular events. METHODS A total of 72 patients (44 men, 28 women, age 58 +/- 8 years) referred for diagnostic cardiac catheterization were studied. Myocardial blood flow was measured in absolute units with (13)N-ammonia using PET, at baseline and during CPT in each patient. Cardiovascular events (cardiovascular death, acute coronary syndrome, myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, ischemic stroke, or peripheral revascularization) were assessed as clinical outcome parameters over a mean follow-up period of 66 +/- 8 months. Patients were assigned to three groups: group 1, patients with >/=40% increase in MBF (%DeltaMBF), n = 22; group 2, patients with >0 and <40% increases in MBF, n = 32; and group 3, patients with decreases in MBF (</=0%), n = 18. RESULTS During follow-up, one of the group 1 patients developed a cerebral stroke. In group 2, 15 cardiovascular events occurred in 9 patients and in group 3, 7 patients experienced 9 cardiovascular events (p </= 0.0001, univariate by log-rank test). Impaired MBF increases in group 2 and group 3 were associated with a significantly higher incidence of cardiovascular events by Kaplan-Meier analysis (p = 0.033, log-rank test). After adjusting for known coronary risk factors, MBF responses to CPT revealed a nonsignificant trend to be independently associated with a higher incidence for cardiovascular events (p = 0.065, multivariate by Cox regression model). CONCLUSIONS Noninvasive PET-measured impaired MBF increases to sympathetic stimulation are associated with the risk of developing cardiovascular events.

[1]  Cyrill Burger,et al.  Bicycle exercise stress in PET for assessment of coronary flow reserve: repeatability and comparison with adenosine stress. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  T. Lüscher,et al.  Coronary Heart Disease in Smokers: Vitamin C Restores Coronary Microcirculatory Function , 2000, Circulation.

[3]  A. Ignaszewski,et al.  The prognostic importance of endothelial dysfunction and carotid atheroma burden in patients with coronary artery disease. , 2003, Journal of the American College of Cardiology.

[4]  M. Pfisterer,et al.  Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[5]  D. Celermajer,et al.  Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.

[6]  D. Berman,et al.  Stress myocardial perfusion single-photon emission computed tomography is clinically effective and cost effective in risk stratification of patients with a high likelihood of coronary artery disease (CAD) but no known CAD. , 2004, Journal of the American College of Cardiology.

[7]  A. Nitenberg,et al.  Impairment of coronary microvascular dilation in response to cold pressor--induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. , 2001, Diabetes.

[8]  John O. Prior,et al.  Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors , 2004, Circulation.

[9]  R. Hendel,et al.  The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  John O. Prior,et al.  PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  A. Nitenberg,et al.  Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. , 2004, Diabetes care.

[12]  J. Loscalzo Functional polymorphisms in a candidate gene for atherothrombosis: unraveling the complex fabric of a polygenic phenotype. , 2003, Journal of the American College of Cardiology.

[13]  R. Pop-Busui,et al.  Sympathetic dysfunction in type 1 diabetes: association with impaired myocardial blood flow reserve and diastolic dysfunction. , 2004, Journal of the American College of Cardiology.

[14]  A. Tajik,et al.  Erratum: Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound (J. Am. Coll. Cardiol. (1995) 26 (41-49)) , 1995 .

[15]  H. Drexler,et al.  Endothelial Dysfunction of the Coronary Microvasculature Is Associated With Impaired Coronary Blood Flow Regulation in Patients With Early Atherosclerosis , 1991, Circulation.

[16]  A. Quyyumi,et al.  Prognostic Value of Coronary Vascular Endothelial Dysfunction , 2002, Circulation.

[17]  S S Gambhir,et al.  Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging , 1992, Circulation.

[18]  H. Drexler,et al.  Flow-dependent coronary artery dilatation in humans. , 1989, Circulation.

[19]  D. Berman,et al.  Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. , 2004, Journal of the American College of Cardiology.

[20]  H. Schelbert,et al.  Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. , 1996, Circulation.

[21]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[22]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[23]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[24]  D. Berman,et al.  Implications of estimating coronary heart disease risk in the US population. , 2004, Journal of the American College of Cardiology.

[25]  M. Pfisterer,et al.  Coronary vasoregulation in patients with various risk factors in response to cold pressor testing: contrasting myocardial blood flow responses to short- and long-term vitamin C administration. , 2003, Journal of the American College of Cardiology.

[26]  J. Keaney,et al.  The clinical implications of endothelial dysfunction. , 2003, Journal of the American College of Cardiology.

[27]  Amir Lerman,et al.  Endothelial Dysfunction: A Marker of Atherosclerotic Risk , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[28]  A. Tajik,et al.  Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. , 1995, Journal of the American College of Cardiology.

[29]  P. Ganz,et al.  Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. , 1989, Circulation.